Abstract:Multiresponsive nanoprobes are highly desirable for low background and highly sensitive imaging in biomedical applications. Herein, we design a glutathione (GSH)/pH dual-responsive nanoprobe capable of both fluorescence imaging in cells and 19F magnetic resonance imaging (19F MRI) in deep tissue, by encapsulating manganese oleate (Mn(OA)2) on the surface of fluorinated fluorescent quantum dots (F-ZnS:Mn2+). In this approach, Mn(OA)2 serves as an efficient quencher of both fluorescence and 19F MRI signal. Both the fluorescence and 19F MRI signal can be turned on by introducing glutathione (GSH) that breaks up the Mn–O bonds within Mn(OA)2 under weak acidity conditions (e.g., pH 6.0). The imaging results in cells and mice suggest that this novel strategy can offer a promising nanoprobe for turn-on fluorescence/19F MRI dual-modal tumor imaging.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c01786?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c01786</a>.XRD pattern of ZnS:Mn2+ QDs (Figure S1); HRTEM images of ZnS:Mn2+-F-Mn(OA)2@PSIOAm before and after reaction with GSH (Figure S2); FT-IR spectra of ZnS:Mn2+ QDs (the ligand is oleic acid), Mn(OA)2, PFCE, PSIOAm, and ZnS:Mn2+-F-Mn(OA)2@PSIOAm (Figure S3); UV–Vis absorption spectrum of Mn(OA)2 and fluorescence spectra of ZnS:Mn2+@PSIOAm and ZnS:Mn2+-Mn(OA)2@PSIOAm (Figure S4); UV–Vis absorption of ZnS:Mn2+OAm and ZnS:Mn2+-F-Mn(OA)2@PSIOAm (Figure S5); 19F NMR spectra of ZnS:Mn2+-F-Mn(OA)2@PSIOAm aqueous solution before and after reaction with GSH (10 mM) at pH 6.0 (Figure S6); UV–Vis absorption spectra and ICP-OES measurements of the Mn content in the supernatants of ZnS-Mn(OA)2@PSIOAm colloidal solution under different conditions (Figure S7); selectivity of ZnS:Mn2+-F-Mn(OA)2@PSIOAm toward GSH (Figure S8); cytotoxicity tests of ZnS:Mn2+-F-Mn(OA)2@PSIOAm colloids after incubation with HUVECs and 4T1 cell lines (Figure S9); flow cytometry analysis of MREpiC and 4T1 cells incubated with ZnS:Mn2+-F-NLR-Mn(OA)2@PSIOAm (Figure S10); stability evaluation of ZnS:Mn2+-F-Mn(OA)2@PSIOAm colloid solution (Figure S11); T1-weighted and T2-weighted 1H MR imaging of ZnS:Mn2+-F-Mn(OA)2@PSIOAm under different conditions (Figure S12); and fluorescence images of 4T1 cells cultured with ZnS:Mn2+-F-Mn(OA)2@PSIOAm nanoprobes for different time (Figure S13) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c01786/suppl_file/ac0c01786_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Bimetallic Zeolitic Imidazolate Framework As an Intrinsic Two-Photon Fluorescence and Ph-Responsive MR Imaging Agent

Dual-Stimulus-Triggered Programmable Drug Release and Luminescent Ratiometric Ph Sensing from Chemically Stable Biocompatible Zinc Metal-Organic Framework.

Manganese-Zeolitic Imidazolate Frameworks-90 with High Blood Circulation Stability for MRI-Guided Tumor Therapy

A Combination of Glioma in Vivo Imaging and in Vivo Drug Delivery by Metal-Organic Framework Based Composite Nanoparticles.

In Situ Multimodality Imaging of Cancerous Cells Based on a Selective Performance of Fe2+-Adsorbed Zeolitic Imidazolate Framework-8

Acid-Responsive Decomposable Nanomedicine Based on Zeolitic Imidazolate Frameworks for Near-Infrared Fluorescence Imaging/Chemotherapy Combined Tumor Theranostics

Manganese Oxide/metal-Organic Frameworks-Based Nanocomposites for Tumr Micro-environment Sensitive 1H/19F Dual-mode Magnetic Resonance Imaging in Vivo

The Progress and Prospect of Zeolitic Imidazolate Frameworks in Cancer Therapy, Antibacterial Activity, and Biomineralization

Core-shell Metal-Organic Frameworks with Fluorescence Switch to Trigger an Enhanced Photodynamic Therapy

Simple One Step Synthesis of Magnetic-optical Dual Functional ZIF-8 in Sodalite Phase for Magnetically Guided Targeting Bioimaging and Drug Delivery

Nanoscale Zeolitic Imidazolate Framework (ZIF)–8 in Cancer Theranostics: Current Challenges and Prospects

Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy

Multiresponsive Nanoprobes for Turn-On Fluorescence/ 19 F MRI Dual-Modal Imaging

Fe3o4-Zif-8 Assemblies As Ph And Glutathione Responsive T-2-T-1 Switching Magnetic Resonance Imaging Contrast Agent For Sensitive Tumor Imaging In Vivo

Pressure-induced amorphous zeolitic imidazole frameworks with reduced toxicity and increased tumor accumulation improves therapeutic efficacy In vivo

Acid-Responsive Multifunctional Zeolitic Imidazolate Framework-8 (ZIF-8) Nanocomposites for Tumor Chemo-Photothermal Synergistic Therapy

Fe<sub>3</sub>O<sub>4</sub>–ZIF-8 assemblies as pH and glutathione responsive <i>T</i><sub>2</sub>–<i>T</i><sub>1</sub> switching magnetic resonance imaging contrast agent for sensitive tumor imaging <i>in vivo</i>

Tuning Luminescence of the Fluorescent Molecule 2-(2-hydroxyphenyl)-1h-benzimidazole Via Zeolitic Imidazolate Framework-8

Mixed Metal Metal–Organic Frameworks Derived Carbon Supporting ZnFe 2 O 4 /C for High-Performance Magnetic Particle Imaging

99mTc-conjugated manganese-based mesoporous silica nanoparticles for SPECT, pH-responsive MRI and anti-cancer drug delivery.

Hydrogen-Bonded Organic Frameworks Chelated Manganese for Precise Magnetic Resonance Imaging Diagnosis of Cancers